The National Institutes of Health announced today its first wave of investments totaling $46 million in fiscal year 14 funds to support the goals of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative.
The United States is in danger of losing its biomedical edge to countries that are...
An AIDS research team at Iowa State University will not get the final $1.38 million payment of a...
Responding to a major case of research misconduct, federal prosecutors have taken the rare step...
More than 5 million Americans suffer from Alzheimer’s disease, the affliction that erodes memory and other mental capacities, but no drugs targeting the disease have been approved by the U.S. Food and Drug Administration since 2003. Now a paper by an MIT professor suggests that a revamped way of financing Alzheimer’s research could spur the development of useful new drugs for the illness.
President Barack Obama announced a new initiative at the National Institutes of Health in pursuit of a cure for HIV, saying his administration is redirecting $100 million into the project to find a new generation of therapies.
According to a recent National Science Foundation study, state government agency expenditures for R&D totaled $1.4 billion in fiscal year 2011, an 11 percent increase over the $1.3 billion reported in FY 2010.
Three U.S.-based scientists won this year's Nobel Prize in chemistry on Wednesday for developing powerful computer models that researchers use to understand complex chemical interactions and create new drugs.
James Rothman, 62, of Yale University, Randy Schekman, 64, of the University of California, Berkeley, and Dr. Thomas Sudhof, 57, of Stanford University shared the $1.2 million Nobel prize in medicine for discovering how key substances are transported within cells, a process involved in such important activities as brain cell communication and the release of insulin.
Patients hoping to enroll for treatment in cutting-edge research studies at the NIH's renowned hospital will have to seek care elsewhere during the government shutdown. Each week that a shutdown lasts would force the agency's research-only hospital to turn away an an estimated 200 patients, 30 of them children.
Brian Pollok is the University of Virginia's newest advocate for commercializing research discoveries that emerge on Grounds. It's a role he'll hold formally as UVa's first entrepreneur-in-residence. In that capacity, he'll work with UVa Innovation and the university's Licensing and Ventures, where he will offer guidance, perspective and a voice on how researchers can amplify their discoveries.
Three scientists at universities in Pennsylvania, Illinois and Oregon whose research has helped transform cancer treatment will share one of the richest prizes in medicine and biomedical research. Dr. Peter Nowell of the University of Pennsylvania, Dr. Janet Rowley of the University of Chicago...
The U.S. Department of Energy has awarded the University of Wisconsin and Michigan State University $125 million to continue their work on advanced biofuels.
Researchers at Sandia National Laboratories are developing a medical instrument that will be able to quickly detect a suite of biothreat agents, including anthrax, ricin, botulinum, shiga and SEB toxin.
At the Massachusetts Institute of Technology, faculty fret about the future of the school's Plasma Science and Fusion Center. Thirty miles away, administrators at the state university campus in Lowell worry that research aimed at designing better body armor for soldiers could suffer.
Nancy Pelosi, Democratic leader of the U.S. House of Representatives, said that the federal government’s budget cuts through sequestration hurt the health and wellbeing of Americans.
Sanford-Burnham Medical Research Institute (Sanford-Burnham) and Mayo Clinic signed a new collaborative agreement to build a pipeline of therapeutic drugs aimed at a variety of diseases with serious unmet medical needs.
Despite dire predictions in the wake of the economic crisis, donations to health projects in developing countries appear to be holding steady, according to new research from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. After reaching a historic high of $28.2 billion in 2010, development assistance for health dropped in 2011 and recovered in 2012.
The Chinese government will give a boost to the biotechnology industry in order to tackle problems related to population growth, food safety, energy conservation and environmental protection, the State Council said. The government aims to double the share of GDP that the sector's value-added output accounts for by 2015 from the 2010 level.
Global research and development (R&D) spending is forecast to grow by 3.7 percent, or $53.7 billion in 2013 to $1.5 trillion, according to the closely watched forecast by Battelle and R&D Magazine. While much remains uncertain about the future of the U.S. R&D enterprise, China’s march to prominence in the global R&D arena accounts for $23. billion on the coming year’s projected growth.